Malarial pigment haemozoin, IFN-gamma, TNF-alpha, IL-1beta and LPS do not stimulate expression of inducible nitric oxide synthase and production of nitric oxide in immuno-purified human monocytes
Open Access
- 2 June 2007
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 6 (1) , 73
- https://doi.org/10.1186/1475-2875-6-73
Abstract
Background: Enhanced production of nitric oxide (NO) following upmodulation of the inducible isoform of NO synthase (iNOS) by haemozoin (HZ), inflammatory cytokines and LPS may provide protection againstPlasmodium falciparummalaria by killing hepatic and blood forms of parasites and inhibiting the cytoadherence of parasitized erythrocytes (RBC) to endothelial cells. Monocytes and macrophages are considered to contribute importantly to protective upregulation of iNOS and production of NO. Data obtained with murine phagocytes fed with human HZ and synthetic HZ (sHZ) indicate that supplemental treatment of those cells with IFN-gamma elicited significant increases in protein and mRNA expression of iNOS and NO production, providing a potential mechanism linking HZ phagocytosis and increased production of NO. Purpose of this study was to analyse the effect ofP. falciparumHZ and sHZ supplemental to treatment with IFN-gamma and/or a stimulatory cytokine-LPS mix on iNOS protein and mRNA expression in immuno-purified human monocytes.Methods: Adherent immunopurified human monocytes (purity >85%), and murine phagocytic cell lines RAW 264.7, N11 and ANA1 were fed or not withP. falciparumHZ or sHZ and treated or not with IFN-gamma or a stimulatory cytokine-LPS mix. Production of NO was quantified in supernatants, iNOS protein and mRNA expression were measured after immunoprecipitation and Western blotting and quantitative RT-PCT, respectively.Results: Phagocytosis of HZ/sHZ by human monocytes did not increase iNOS protein and mRNA expression and NO production either after stimulation by IFN-gamma or the cytokine-LPS mix. By contrast, in HZ/sHZ-laden murine macrophages, identical treatment with IFN-gamma and the cytokine-LPS mix elicited significant increases in protein and mRNA expression of iNOS and NOS metabolites production, in agreement with literature data.Conclusion: Results indicate that human monocytes fed or not with HZ/sHZ were constantly unable to express iNOS and generate NOS metabolites even after stimulation with IFN-gamma or a cytokine-LSP mix that were very active on HZ-fed murine phagocytic lines. Present data do not support the hypothesis that monocytes are mediators of anti-parasitic defence in clinical malaria via activation of iNOS and production of NO, and suggest caution in extrapolating data obtained with murine or hybrid systems to human malaria.Keywords
This publication has 38 references indexed in Scilit:
- Nitric oxide bioavailability in malariaTrends in Parasitology, 2005
- Nitric Oxide Production and Nitric Oxide Synthase Activity in Malaria-Exposed Papua New Guinean Children and Adults Show Longitudinal Stability and No Association with ParasitemiaInfection and Immunity, 2004
- A critical role for C/EBPβ binding to the AABS promoter response element in the human iNOS geneThe FASEB Journal, 2003
- Species differences in macrophage NO production are importantNature Immunology, 2002
- Nitric Oxide Synthase 2Lambaréné(G‐954C), Increased Nitric Oxide Production, and Protection against MalariaThe Journal of Infectious Diseases, 2001
- Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.The Journal of Experimental Medicine, 1996
- Human monocytes cultured with and without interferon‐gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediatesParasite Immunology, 1994
- Reduced microbicidal and anti‐tumour activities of human monocytes after ingestion of Plasmodium falciparum‐infected red blood cellsParasite Immunology, 1993
- Sequences and Factors: A Guide to MHC Class-II TranscriptionAnnual Review of Immunology, 1992
- Human Ia molecules carrying DC1 determinants differ in both α- and β-subunits from Ia molecules carrying DR determinantsNature, 1981